Navigation Links
Mr. William Lerner, Esq. nominated to the Board of Directors of Sanomedics International Holdings, Inc.

MIAMI, March 8, 2013 /PRNewswire/ -- Sanomedics International Holdings, Inc. (OTCQB: SIMH), a medical technology holding Company that focuses on game changing products, services and ideas, announces that William Lerner, Esq. has been nominated to serve as a director of the Company.

Mr. Lerner, a graduate of Cornell University and of the New York University School of Law, is a member of the bars of New York and Pennsylvania, with a Peer Rating for more than 25 years of AV ( Martindale Hubbell ). His career includes service with the U.S. Securities & Exchange Commission, The American Stock Exchange and as General Counsel to a major New York Stock Exchange brokerage/investment banking/financial services firm. Most recently Mr. Lerner has been and is engaged in the private practice of corporate and securities law in New York and in Pennsylvania, and in Toronto, Canada as a Consultant in providing strategic and legal consulting as well as corporate governance and crisis management services to both public and private companies both in the United States and in Canada.

Mr. Lerner is also a member of the Board of Trustees (and Chairman of the Compliance Committee) of the Daily Income Fund, a money market mutual fund whose portfolio is managed by Reich & Tang Asset Management, LLC (NYC). The Manager is an affiliate of Natixis Global Asset Management headquartered in Paris, France and Boston, Massachusetts.

Mr. Lerner is a director of National Holdings Corporation, a holding company for National Securities Corporation, vFinance Investments, Inc., National Asset Management, Inc. and National Insurance Corporation. National Securities and vFinance are broker-dealers registered with the Securities and Exchange Commission, and members of FINRA and SIPC. National Asset Management is an SEC registered investment adviser, and National Insurance provides a full array of fixed insurance products. (See:

Mr. Lerner is an adviser to Fiduciary Compliance Associates LLC (formed by Charles Lerner Esq. , former Special Counsel to the Division of Enforcement at the SEC  in Washington, DC and Director of Enforcement at the Pension and Welfare Benefits Administration at the US Department of Labor). Fiduciary Compliance ( provides full service compliance support to investment advisers, private investment funds, and financial firms in the US and Europe.

Sanomedics International Holdings Keith Houlihan, Co-founder and President stated, "We are very excited to have someone of Mr. Lerner's caliber and experience on our Board to help guide us as we implement our strategy and take advantage of the market opportunities ahead."

Additionally the Company announces acceptance of the resignation of its CEO, Mr. Dom Gatto effective March 8, 2013. Mr. Gatto gladly offered to assist the Company during the transition and search for a replacement. Pending a replacement the company's present management team will share in the CEO's responsibilities. 

About Sanomedics
Sanomedics International Holdings, Inc. (SIMH) is a medical technology holding company that focuses on game changing products, services and ideas – a place where physicians, entrepreneurs, and medical companies can work together to drive innovative technologies through concept, development, and ultimately commercialization. We plan to grow our existing business organically and through strategic acquisitions specifically relating to sleep disorder diagnosis treatments. Sanomedics seeks to acquire sleep therapy operating businesses and our strategy is to integrate a portfolio of world-class products and service providers in the growing Sleep Apnea market. Our goal is to provide Sleep Apnea patients with a reliable and integrated "end-to-end" service platform.

Forward Looking Statements
This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. The Company's periodic filings with the Securities and Exchange Commission should be viewed for a complete understanding of risk and uncertainty.

Contact: Keith Houlihan , 305-433-7814,

SOURCE Sanomedics International Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MEI Pharma Announces Retirement Of Chairman Bryan Williams From Board Of Directors And Appointment Of Christine White As Lead Director
2. Huntington Memorial Hospital Elects Paul Johnson, Deborah Williams to its Board of Directors
3. Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
4. BD Announces Appointment of William A. Kozy as Chief Operating Officer
5. Aushon BioSystems ernennt Bill Williams zum neuen Vice President of Sales
6. Aushon BioSystems Appoints Bill Williams Vice President of Sales
7. IRIDEX Appoints Chairman William M. Moore as Interim President & CEO
8. Lippincott Williams & Wilkins Launches Electronic Health Record (EHR) Learning Tool to Help Future Nurses Prepare for New Practice Requirements
9. Covance To Present At The William Blair 32nd Annual Growth Stock Conference
10. Perrigo Company To Present At The William Blair Growth Stock Conference
11. Stereotaxis Appoints William C. Mills III as Chairman of Board of Directors
Post Your Comments:
(Date:12/1/2015)... Russia has always been a country of choice for ... Europe in 2015 were tested in phase II-III ... has always been a country of choice for global multi-center phase ... in 2015 were tested in phase II-III clinical trials ... always been a country of choice for global multi-center phase III clinical ...
(Date:12/1/2015)... ANGELES , Dec. 1, 2015 CytRx ... development company specializing in oncology, today announced that it ... the company,s pivotal global Phase 3 clinical trial of ... (STS). Enrollment was originally estimated to be completed in Q1 ... being conducted under a Special Protocol Assessment from the ...
(Date:12/1/2015)... , Dec. 1, 2015  The migration to ... develop shared care plans that help patients stay ... plans will be digitally enabled, incorporate care guidelines ... and desires. They will also allow all stakeholders ... health journey is optimal. That is the vision, ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 01, 2015 , ... Physicians’ Education Resource®, LLC (PER®) ... announced that the first annual School of Gastrointestinal Oncology™ (SOGO™) will be held ... treatment of gastrointestinal cancers are undergoing transformational change, providing oncologists with powerful new ...
(Date:12/1/2015)... ... December 01, 2015 , ... Speech and ... believe that with innovative technologies and under the right circumstances, these practices can ... benefit of a dual-approach to his or her therapeutic sessions, as well as ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... the 7th Annual 2015 Golden Bridge Business Awards under the New Products and ... zero capex web based sample management software that helps labs organize ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of volumetric ... the focus of numerous abstracts accepted for presentation here, at the 101st Annual ... abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software tools for ...
(Date:12/1/2015)... ... December 01, 2015 , ... SAN FRANCISCO, Calif. ... that the organization has awarded Education and Developmental Therapies (EDT), an Applied Behavior ... award celebrates exceptional special needs providers that excel in synthesizing the areas of ...
Breaking Medicine News(10 mins):